发明授权
US06638942B1 Spiro-indolines as Y5 receptor antagonists 失效
螺吲哚啉作为Y5受体拮抗剂

Spiro-indolines as Y5 receptor antagonists
摘要:
Compounds of general structural formula I are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.
信息查询
0/0